Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostatChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Jan Samuelsson et al.|Leukemia Research|2014Cited by 13
Circulating YKL-40 in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV) treated with the Novel Histone Deacetylase Inhibitor VorinostatChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Mads Emil Bjørn et al.|University of Southern Denmark Research Portal (University of Southern Denmark)|2013Cited by 0